Opdivo ads vs. the reality of stage IV cancer treatment
Birds, hares, and tortoises: What do they have to do with the recent news on cancer screening?
What the media got wrong about Jimmy Carter’s cancer “cure”
Is it ok for journalists to attend Bayer-funded training on new cancer treatments?
A patient’s perspective on recent prostate cancer screening news
Mayo spins rosy tale on Cologuard cancer screen — ignoring costs, false-positives and other crucial context
The hospital-media partnership: promoting public health or inducing public demand?
Journalists love superlative terms for cancer drugs – often questionably
Is 1 in 7 Odds a Breakthrough? Is it Even Promising?
Biden resurrects false promise of cancer “Moonshot”